Literature DB >> 7925209

Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients.

J A Alvarez-Gomez1, M E Estelles, J Fabregat, F Perez, A J Brugger.   

Abstract

In seven patients (M/F: 4:3) rocuronium 0.6 mg kg-1 was given after the induction of anaesthesia with propofol, and during maintenance with N2O/O2, halothane 0.5% and alfentanil 60-90 micrograms kg-1 h-1. Intubation conditions were scored at 60 s and lag time, onset time, maximal block achieved, recovery to 25% of T1, and Recovery Index, were measured using a Relaxograph. Blood samples were taken over a 300 min period and analysed for rocuronium. Intubating conditions at 60 s were excellent in all patients. Mean clearance was 5.2 ml kg-1 min-1, the terminal half-life was 69 min and distribution volume at steady state was 0.22 litre kg-1. Cumulative urinary excretion was around 18% within 24 h.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925209

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  7 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models.

Authors:  Kenichi Masui; Sayaka Ishigaki; Atsuko Tomita; Hiroshi Otake
Journal:  J Anesth       Date:  2018-08-11       Impact factor: 2.078

Review 4.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  Rocuronium bromide: clinical application of single-dose pharmacokinetic models to continuous infusion.

Authors:  Yutaka Oda
Journal:  J Anesth       Date:  2017-08-21       Impact factor: 2.078

6.  Effect of remimazolam on intraoperative neuromonitoring during thyroid surgery: a case series.

Authors:  Kengo Hayamizu; Tomohiro Chaki; Shunsuke Tachibana; Naoyuki Hirata; Michiaki Yamakage
Journal:  J Anesth       Date:  2021-06-05       Impact factor: 2.078

7.  The predictive ability of six pharmacokinetic models of rocuronium developed using a single bolus: evaluation with bolus and continuous infusion regimen.

Authors:  Tomoki Sasakawa; Kenichi Masui; Tomiei Kazama; Hiroshi Iwasaki
Journal:  J Anesth       Date:  2016-04-20       Impact factor: 2.078

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.